Hereditary Cancer Syndromes: Molecular Basis

Hereditary cancer syndromes are inherited conditions in which a germline mutation, present from birth in every cell, substantially raises the risk of developing one or more cancers. Their molecular basis usually lies in inherited inactivation of a tumour suppressor or DNA repair gene, which provides the first of the two hits needed for tumour development and explains the earlier-onset, often multiple, cancers seen in affected families.

Definition

A hereditary cancer syndrome is an inherited disorder, typically caused by a germline mutation in a tumour suppressor or DNA repair gene, that markedly increases an individual's lifetime risk of specific cancers.

Scope

This topic covers the molecular logic of inherited cancer predisposition: germline alteration of tumour suppressor and caretaker genes, the two-hit model applied to familial cases, and representative syndromes such as Li-Fraumeni syndrome (TP53), hereditary breast and ovarian cancer (BRCA1/BRCA2), and Lynch syndrome (mismatch-repair genes). It is presented as a molecular pathology reference and not as guidance on personal risk, testing, or management.

Core questions

• How does an inherited germline mutation predispose to cancer?
• How does the two-hit hypothesis explain earlier and bilateral cancers in familial cases?
• Which gene classes most commonly underlie hereditary cancer syndromes?
• How do germline-driven cancers relate to their sporadic counterparts?

Key concepts

• Germline versus somatic mutation
• Inherited first hit and loss of heterozygosity
• Tumour suppressor and caretaker gene predisposition
• Li-Fraumeni syndrome (TP53)
• Hereditary breast and ovarian cancer (BRCA1/BRCA2)
• Lynch syndrome and mismatch-repair deficiency

Key theories

Inherited first hit (germline two-hit model)

In hereditary cancer syndromes the affected individual inherits one already-inactivated allele of a tumour suppressor gene, so only a single additional somatic hit is needed to lose function in a cell; this explains the earlier onset and frequent multiplicity of tumours compared with sporadic cases, as first inferred from retinoblastoma.

Defective genome maintenance as predisposition

Several syndromes arise from inherited defects in DNA repair or homologous recombination — as in mismatch-repair deficiency in Lynch syndrome and BRCA-related repair defects — so that genome instability, rather than a direct growth signal, drives the elevated cancer risk.

Mechanisms

Most hereditary cancer syndromes follow autosomal-dominant inheritance at the level of risk because affected individuals carry one defective allele of a tumour suppressor or repair gene in every cell; at the cellular level the trait behaves recessively, requiring loss of the remaining normal allele. Inheriting that first hit shifts the threshold for tumour formation, accounting for younger age at onset and multiple primary tumours. The genes involved typically encode either gatekeepers that restrain proliferation, such as TP53 in Li-Fraumeni syndrome, or caretakers that maintain genome integrity, such as the mismatch-repair genes in Lynch syndrome and BRCA1/BRCA2 in homologous-recombination repair; their germline loss links inherited predisposition to the same oncogene/tumour-suppressor and instability mechanisms seen in sporadic cancer.

Clinical relevance

Hereditary cancer syndromes are central to molecular and genetic pathology because they connect germline genetics to tumour biology and to the molecular features used in tumour classification. This entry describes the underlying molecular mechanisms for educational reference only; it is not a basis for individual risk assessment, genetic testing decisions, or management.

History

Knudson's 1971 analysis of retinoblastoma provided the conceptual model for inherited cancer predisposition, and molecular cloning in the 1990s identified the genes behind major syndromes, including germline TP53 in Li-Fraumeni syndrome and BRCA1 in hereditary breast and ovarian cancer, alongside characterisation of mismatch-repair defects in Lynch syndrome. These discoveries unified inherited and sporadic cancer within a shared molecular framework.

Key figures

• Alfred Knudson
• Henry Lynch
• Mary-Claire King
• Frederick Li
• Joseph Fraumeni

Seminal works

• knudson-1971
• malkin-1990
• miki-1994
• lynch-delachapelle-2003

Frequently asked questions

Why do hereditary cancers often appear at a younger age?

Because an affected person inherits one already-inactivated copy of a relevant gene in every cell, only one further change is needed for a cell to lose its function, so tumours can arise earlier and at multiple sites compared with sporadic cancer.

Are hereditary cancer syndromes caused by oncogenes?

Most are caused by inherited inactivation of tumour suppressor or DNA repair genes rather than activation of oncogenes, which is why both gene copies must be lost for cancer to develop.